Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Vet World ; 10(7): 727-731, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28831212

ABSTRACT

AIM: Objective of this study was to investigate the effect of multicarbohydrases supplementation on performance of broilers fed low energy diet. MATERIALS AND METHODS: A total of 75 days old chicks were selected and randomly divided into three treatments groups (T1, T2, and T3); each group contained 25 chicks distributed in five replicates of five chicks each. T1 group (positive control) was offered control ration formulated as per Bureau of Indian Standards recommendations. In T2 group (negative control) ration, metabolizable energy (ME) was reduced by 100 kcal/kg diet. T3 group ration was same as that of T2 except that it was supplemented with multicarbohydrases (xylanase at 50 g/ton+mannanase at 50 g/ton+amylase at 40 g/ton). Feed intake and body weight of all experimental birds were recorded weekly. Metabolic trial was conducted for 3 days at the end of experiment to know the retention of nutrients. RESULTS: Significant improvement (p<0.01) was observed in total weight gain, feed conversion efficiency, and performance index in broilers under supplementary group T3 as compared to T1 and T2 groups. Retention of crude protein and ether extract was significantly increased (p<0.05) in T3 group supplemented with multicarbohydrases as compared to other groups. Retention of dry matter, crude fiber, and nitrogen-free extract was comparable in all the three groups. Significantly highest dressed weight, eviscerated weight, and drawn weight (% of live body weight) were observed in multicarbohydrases supplemented T3 group, however it was comparable in T1 and T2 groups. CONCLUSION: It was concluded that the supplementation of multicarbohydrases (xylanase at 50 g/ton+mannanase at 50 g/ton+amylase at 40 g/ton) in low energy diet improved overall performance of broilers.

2.
Luminescence ; 32(3): 375-381, 2017 May.
Article in English | MEDLINE | ID: mdl-28394484

ABSTRACT

The present paper reports the thermoluminescence (TL) of (ZnS)1-x (MnTe)x nanophosphors that were prepared by a wet chemical synthesis method. The structure investigated by X-ray diffraction patterns confirms the formation of a sphalerite phase whose space group was found to be F 4¯3m. From XRD, TEM and SEM analyses the average sizes of the particles were found to be 12 nm, 11 nm and 15 nm, respectively. Initially the TL intensity increased with increasing values of x because the number of luminescence centres increased; however, for higher values of x the TL intensity decreased because of the concentration quenching. Thus the TL, mechanoluminescence and photoluminescence intensities are optimum for a particular value of x, that is for x = 0.05. Thermoluminescence of the (ZnS)1-x (MnTe)x nanophosphor has not been reported previously. There were two peaks seen in the thermoluminescence glow curves in which the first peak lay at 105-100 °C and the second peak lay at 183.5-178.5 °C. The activation energies for the first and second peaks were found to be 0.45 eV and 0.75 eV, respectively.


Subject(s)
Luminescence , Nanoparticles/chemistry , Sulfides/chemistry , Tellurium/chemistry , Temperature , Zinc Compounds/chemistry , Luminescent Measurements , Particle Size , Surface Properties
3.
Pharmacogenomics J ; 17(3): 242-251, 2017 06.
Article in English | MEDLINE | ID: mdl-26951882

ABSTRACT

CYP1A1 gene is involved in estrogen metabolism, and previously, we have reported association of variant rs2606345 with altered anti-epileptic drugs (AED) response in North Indian women with epilepsy (WWE). The present study aims to replicate the pharmacogenetic association, perform functional characterization and study its distribution within ethnically diverse Indian population. The variant was genotyped in 351 patients to assess the pharmacogenetic association and 552 healthy individuals belonging to 24 different ethnic groups to examine the distribution in Indian population. We observed significant overrepresentation of 'A' allele and 'AA' genotype in poor responders in WWE at Bonferroni-corrected significance levels. The recessive allele was found to lower the promoter activity by ~70-80% which was further substantiated by thermally less stable hairpin formed by it (ΔTm=7 °C). Among all ethnic groups, west Indo-European (IE-W-LP2) subpopulation showed highest genotypic frequency of the variant making women from this community more prone to poor AED response. Our results indicate that rs2606345 influences drug response in WWE by lowering CYP1A1 expression.


Subject(s)
Anticonvulsants/therapeutic use , Cytochrome P-450 CYP1A1/genetics , Epilepsy/drug therapy , Pharmacogenomic Variants , Adolescent , Adult , Anticonvulsants/adverse effects , Case-Control Studies , Cytochrome P-450 CYP1A1/metabolism , Epilepsy/enzymology , Epilepsy/ethnology , Epilepsy/genetics , Female , Gene Frequency , HEK293 Cells , Heterozygote , Homozygote , Humans , India/epidemiology , MCF-7 Cells , Male , Pharmacogenetics , Pharmacogenomic Testing , Phenotype , Promoter Regions, Genetic , Racial Groups/genetics , Recurrence , Transfection , Treatment Outcome , Young Adult
4.
Vet World ; 9(6): 554-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27397975

ABSTRACT

AIM: Objective of this study was to investigate the effect of different levels of iodine supplementation on iodine content of eggs in laying hens. MATERIALS AND METHODS: In the experiment, 135 laying hens (White Leghorn) of 55 weeks age were randomly distributed to 5 dietary treatments; each group contained 27 laying hens distributed in three replicates of 9 birds each. Diet T1 was control basal layer diet without iodine enrichment in which iodine content (I2) was as per NRC recommendation. Basal diets were supplemented with calcium iodate (Ca (IO3)2) at 5, 10, 15 and 20 mg/kg in T2, T3, T4 and T5 groups, respectively. The iodine content in the calcium iodate is 65.21%, therefore, the diets T2, T3, T4 and T5 contained 3.25, 6.50, 9.75 and 13.0 ppm iodine, respectively. The laying hens were fed the respective experimental diets ad libitum during the experimental period of 10-week. The iodine content of egg yolk and albumen was analyzed at the end of 5(th) and 10(th) week of the experiment. Economics of feeding for the production of iodine enriched egg was calculated at the end of the experiment. RESULTS: Increasing iodine levels in diet of hens from 0.45 to 13.0 ppm significantly increased egg iodine concentration, the highest concentration of egg iodine was observed in the group fed diet supplemented with 13.0 ppm iodine followed by those fed 9.75, 6.50, 3.25 and 0.45 ppm iodine in diet. There was no significant difference in the iodine levels of unboiled versus boiled eggs. Therefore, the consumers are ensured to receive the optimal levels of iodine from boiled iodine-enriched eggs. Among different diets, minimum and significantly lower feeding cost (Rs. per dozen or per kg eggs) was noticed in hens allotted T3 diet (6.50 ppm I2). However, feeding cost of hens receiving 3.25 and 9.25 ppm I2 was statistically (p<0.05) similar to control group (T1). Further, it was noticed that feeding cost (Rs. per dozen or per kg eggs) was significantly increased due to the inclusion of higher level of iodine (13.0 ppm). CONCLUSION: It was concluded that supplementing iodine at 6.50 ppm in layers diet was economically better for the production of iodine enriched eggs followed by feed iodine supplementation at 3.25 ppm as compared to control and other treatment groups.

5.
Luminescence ; 31(2): 478-486, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26332287

ABSTRACT

This paper reports the effect of particle size on the thermoluminescence (TL) of undoped ZnS nanoparticles. ZnS nanoparticles were prepared using a chemical precipitation method in which mercaptoethanol was used as the capping agent. The nanoparticles were characterized by X-ray diffraction, field emission gun-scanning electron microscopy and high-resolution transmission electron microscopy. When the concentrations of mercaptoethanol used are 0, 0.005, 0.01, 0.015, 0.025, 0.040 and 0.060 M, the sizes of the nanoparticles are 2.86, 2.81, 2.69, 2.40, 2.10, 1.90 and 1.80 nm, respectively. Initially, the TL intensity of UV-irradiated ZnS nanoparticles increases with temperature, attains a peak value Im for a particular temperature Tm, and then decreases with further increases in temperature. The values of both Im and Tm increase with decreasing nanoparticle size. Whereas the activation energy decreases slightly with decreasing nanoparticle size, the frequency factor decreases significantly as the nanoparticle size is reduced. The order of kinetics for the TL glow curve of ZnS nanoparticles is 2. Expressions are derived for the dependence of activation energy (Ea) and Tm on nanoparticle size, and good agreement is found between the experimental and theoretical results.


Subject(s)
Luminescence , Nanoparticles/analysis , Nanoparticles/chemistry , Particle Size , Sulfides/chemistry , Temperature , Zinc Compounds/chemistry , Sulfides/analysis , Surface Properties , Zinc Compounds/analysis
6.
Luminescence ; 31(2): 317-322, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26105811

ABSTRACT

ZnS:Mn nanoparticles were prepared by a chemical precipitation method and characterized by X-ray diffraction (XRD), field emission gun scanning electron microscope (FEGSEM), and high resolution transmission electron microscopy (HRTEM). Capping agent (mercaptoethanol) concentrations used were 0 M, 0.005 M, 0.01 M, 0.015 M, 0.025 M, 0.040 M, and 0.060 M, and resulted in nanoparticles sizes of 2.98 nm, 2.9 nm, 2.8 nm, 2.7 nm, 2.61 nm, 2.2 nm and 2.1 nm, respectively. The thermoluminescence (TL) glow curve was recorded by heating the sample exposed to UV-radiation, at a fixed heating rate 1°C sec(-1). The TL intensity initially increased with temperature, attained a peak value Im for a particular temperature, and then decreased with further increase in temperature. The peak TL intensity increased with decreasing nanoparticle size, whereas the temperature corresponding to the peak TL intensity decreased slightly with reducing nanocrystal size. As a consequence of increase in surface-to-volume ratio and increased carrier recombination rates, the TL intensity increased with decreasing nanoparticle size. It was found that, whereas activation energy slightly decreased with decreasing nanoparticle size, the frequency factor decreased significantly with reduction in nanoparticle size.


Subject(s)
Luminescence , Manganese/chemistry , Nanoparticles/chemistry , Sulfides/chemistry , Temperature , Zinc Compounds/chemistry , Luminescent Measurements , Particle Size , Surface Properties
7.
Luminescence ; 31(1): 67-75, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25991045

ABSTRACT

Mathematical approaches made for both the charged dislocation model and piezoelectrically induced electron bombardment model of fracto-mechanoluminescence (FML), the luminescence induced by fracture of solids, in ZnS:Mn phosphor indicate that the piezoelectrically induced electron bombardment model provides a dominating process for the FML of ZnS phosphors. The concentration of 3000 ppm Mn(2+) is optimal for ML intensity of ZnS:Mn phosphor. The decay time of ML gives the relaxation time of the piston used to deform the sample and the time tm of maximum of ML is controlled by both the relaxation time of the piston and decay time of charges on the newly created surfaces of crystals. As the product of the velocity of dislocations and pinning time of dislocations gives the mean free path of a moving dislocation. Both factors play an important role in the ML excitation of impurity doped II-VI semiconductors. The linear increase of total ML intensity IT with the impact velocity indicates that the damage increases linearly with impact velocity of the load. Thus, the ML measurement can be used remotely to monitor the real-time damage in the structures, and therefore, the ML of ZnS:Mn phosphor has also the potential for a structural health monitoring system.


Subject(s)
Luminescence , Manganese/chemistry , Sulfides/chemistry , Zinc Compounds/chemistry
8.
Luminescence ; 31(1): 164-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26084815

ABSTRACT

CaMgSi2O6:Eu(2+),Dy(3+) and CaMgSi2O6:Eu(2+),Ce(3+) phosphors were synthesized using the solid-state reaction method. X-Ray diffraction (XRD) and photoluminescence (PL) analyses were used to characterize the phosphors. The XRD results revealed that the synthesized CaMgSi2O6:Eu(2+),Dy(3+) and CaMgSi2O6:Eu(2+),Ce(3+) phosphors were crystalline and are assigned to the monoclinic structure with a space group C2/c. The calculated crystal sizes of CaMgSi2O6:Eu(2+),Dy(3+) and CaMgSi2O6:Eu(2+),Ce(3+) phosphors with a main (221) diffraction peak were 44.87 and 53.51 nm, respectively. Energy-dispersive X-ray spectroscopy (EDX) confirmed the proper preparation of the sample. The PL emission spectra of CaMgSi2O6:Eu(2+),Dy(3+) and CaMgSi2O6:Eu(2+),Ce(3+) phosphors have a broad band peak at 444.5 and 466 nm, respectively, which is due to electronic transition from 4f(6) 5d(1) to 4f(7). The afterglow results indicate that the CaMgSi2O6:Eu(2+),Dy(3+) phosphor has better persistence luminescence than the CaMgSi2O6:Eu(2+),Ce(3+) phosphor.


Subject(s)
Luminescence , Calcium/chemistry , Cerium/chemistry , Dysprosium/chemistry , Europium/chemistry , Magnesium/chemistry , Oxygen/chemistry , Photochemical Processes , Silicon/chemistry , Spectrometry, X-Ray Emission , X-Ray Diffraction
9.
Luminescence ; 30(7): 1034-40, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25665136

ABSTRACT

A blue CaMgSi2O6:Eu(2+) phosphor was prepared by the solid-state reaction method and the phosphor characterized in terms of crystal structure, particle size, photoluminescence (PL), thermoluminescence (TL) and mechanoluminescence (ML) properties using X-ray diffraction (XRD), transmission electron microscopy (TEM), PL spectroscopy, TLD reader and ML impact technique. The XRD result shows that phosphor is formed in a single phase and has a monoclinic structure with the space group C2/c. Furthermore, the PL excitation spectra of Eu(2+) -doped CaMgSi2 O6 phosphor showed a strong band peak at 356 nm and the PL emission spectrum has a peak at 450 nm. The depths and frequency factors of trap centers were calculated using the TL glow curve by deconvolution method in which the trap depths were found to be 0.48 and 0.61 eV. The formation of CaMgSi2O6:Eu(2+) phosphor was confirmed by Fourier transform infrared spectroscopy. The ML intensity increased linearly with the impact velocity of the piston used to deform the phosphor. It was shown that the local piezoelectricity-induced electron bombardment model is responsible for the ML emission. Finally, the optical properties of CaMgSi2O6:Eu(2+) phosphors are discussed.


Subject(s)
Calcium/chemistry , Europium/chemistry , Luminescence , Magnesium/chemistry , Oxygen/chemistry , Silicon/chemistry , Particle Size , Spectroscopy, Fourier Transform Infrared , Surface Properties , Temperature , X-Ray Diffraction
10.
Curr Med Chem ; 17(22): 2419-30, 2010.
Article in English | MEDLINE | ID: mdl-20491636

ABSTRACT

Lentinus edodes is the first medicinal macrofungus to enter the realm of modern biotechnology. It is the second most popular edible mushroom in the global market which is attributed not only to its nutritional value but also to possible potential for therapeutic applications. Lentinus edodes is used medicinally for diseases involving depressed immune function (including AIDS), cancer, environmental allergies, fungal infection, frequent flu and colds, bronchial inflammation, heart disease, hyperlipidemia (including high blood cholesterol), hypertension, infectious disease, diabetes, hepatitis and regulating urinary inconsistencies. It is the source of several well-studied preparations with proven pharmacological properties, especially the polysaccharide lentinan, eritadenine, shiitake mushroom mycelium, and culture media extracts (LEM, LAP and KS-2). Antibiotic, anti-carcinogenic and antiviral compounds have been isolated intracellularly (fruiting body and mycelia) and extracellularly (culture media). Some of these substances were lentinan, lectins and eritadenine. The aim of this review is to discuss the therapeutic applications of this macrofungus. The potential of this macrofungus is unquestionable in the most important areas of applied biotechnology.


Subject(s)
Anti-Bacterial Agents/pharmacology , Shiitake Mushrooms/therapeutic use , Animals , Humans , Lentinan/isolation & purification , Lentinan/pharmacology , Shiitake Mushrooms/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...